Potential role of annexin A7 in cancers

Clinica Chimica Acta

Volumn 423, Issue , 2013, Pages 83-89

  Guo, Chunmei ^a   Liu, Shuqing ^a   Greenaway, Frederick ^b   Sun, Ming Zhong ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b CLARK UNIVERSITY   (United States)

Author keywords

Annexin A7; Function; Malignancy; Tumor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; SYNEXIN; TUMOR MARKER;

BLADDER CARCINOMA; BREAST CANCER; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER INHIBITION; CANCER PROGNOSIS; CANCER SURVIVAL; CELLULAR DISTRIBUTION; COLORECTAL CANCER; DISEASE ASSOCIATION; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HUMAN; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MOLECULAR PATHOLOGY; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; STOMACH CANCER; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; TUMOR INVASION; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANNEXIN A7; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84878119706     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.04.018     Document Type: Review

References (40)

1. Gerke V., Moss S.E. Annexins: from structure to function. Physiol Rev 2002, 82(2):331-371.
2. Monastyrskaya K., Babiychuk E.B., Draeger A. The annexins: spatial and temporal coordination of signaling events during cellular stress. Cell Mol Life Sci 2009, 66(16):2623-2642.
3. Lim L.H., Pervaiz S. Annexin 1: the new face of an old molecule. FASEB J 2007, 21(4):968-975.
4. Mussunoor S., Murray G.I. The role of annexins in tumour development and progression. J Pathol 2008, 216(2):131-140.
5. Srivastava M., Bubendorf L., Raffeld M., et al. Prognostic impact of ANX7-GTPase in metastatic and HER2-negative breast cancer patients. Clin Cancer Res 2004, 10(7):2344-2350.
6. Srivastava M., Bubendorf L., Nolan L., et al. ANX7 as a bio-marker in prostate and breast cancer progression. Dis Markers 2001, 17(2):115-120.
7. Shirvan A., Srivastava M., Wang M.G., et al. Divergent structure of the human synexin (annexin VII) gene and assignment to chromosome 10. Biochemistry 1994, 33:6888-6901.
8. Torosyan Y., Dobi A., Naga S., et al. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription. Cancer Res 2006, 66(19):9609-9616.
9. Gerelsaikhan T., Vasa P.K., Chander A. Annexin A7 and SNAP23 interactions in alveolar type II cells and in vitro: a role for Ca(2+) and PKC. Biochim Biophys Acta 2012, 1823(10):1796-1806.
10. Chander A., Gerelsaikhan T., Vasa P.K. Annexin A7 trafficking to alveolar type II cell surface: possible roles for protein insertion into membranes and lamellar body secretion. Biochim Biophys Acta 2013, 1833(5):1244-1255.
11. Mears D., Zimliki C.L., Atwater I., et al. The Anx7(+/-) knockout mutation alters electrical and secretory responses to Ca(2+)-mobilizing agents in pancreatic beta-cells. Cell Physiol Biochem 2012, 29(5-6):697-704.
12. Taniuchi K., Yokotani K., Saibara T. BART inhibits pancreatic cancer cell invasion by PKCα inactivation through binding to ANX7. PLoS One 2012, 7(4):e35674.
13. Dong J.T. Prevalent mutations in prostate cancer. J Cell Biochem 2006, 97(3):433-447.
14. Herr C., Smyth N., Ullrich S., et al. Loss of annexin A7 leads to alterations in frequency-induced shortening of isolated murine cardiomyocytes. Mol Cell Biol 2001, 21(13):4119-4128.
15. Hung K.S., Howng S.L. Prognostic significance of annexin VII expression in glioblastomas multiforme in humans. J Neurosurg 2003, 99(5):886-892.
16. Yadav A.K., Renfrow J.J., Scholtens D.M., et al. Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas. JAMA 2009, 302(3):276-289.
17. Bredel M., Scholtens D.M., Harsh G.R., et al. A network model of a cooperative genetic landscape in brain tumors. JAMA 2009, 302(3):261-275.
18. Sun M-Z., Liu S., Tang J. Proteomics investigation of mouse hepatocarcinoma cell lines with different lymph node metastasis capacities. Cheml J Chin Univ 2009, 30:517-524.
19. Sun M-Z., Liu S., Tang J., et al. Proteomics analysis of two mice hepatocarcinoma ascites syngeneic cell lines with high and low lymph node metastasis rates provide potential protein markers for tumor malignancy attributes to lymphatic metastasis. Proteomics 2009, 9:3285-3302.
20. Liu S., Sun M-Z., Tang J., et al. High performance liquid chromatography/nano-electrospray ionization tandem mass spectrometry, two-dimensional difference in-gel electrophoresis and gene microarray identification of lymphatic metastasis-associated biomarker. Rapid Commun Mass Spectrom 2008, 22:3172-3178.
21. Sun M-Z., Liu S., Tang J. Targeting Annexin A7 in hepatocarcinoma lymphatic metastasis. Chin J Lung Cancer 2009, 12(6):633-634.
22. Qazi A.S., Sun M-Z., Huang Y., et al. Subcellular proteomics: determination of specific location and expression levels of lymphatic metastasis associated proteins in hepatocellular carcinoma by subcellular fractionation. Biomed Pharmacother 2011, 65(6):407-416.
23. Srivastava M., Torosyan Y., Raffeld M., et al. ANXA7 expression represents hormone-relevant tumor suppression in different cancers. Int J Cancer 2007, 121(12):2628-2636.
24. Clifton J.G., Brown M.K., Huang F., et al. Identification of members of the annexin family in the detergent-insoluble fraction of rat Morris hepatoma plasma membranes. J Chromatogr A 2006, 1123(2):205-211.
25. Hsu P.I., Huang M., Chen H., et al. The significance of ANXA7 expression and its correlation with poor cellular differentiation and enhanced metastatic potential of gastric cancer. J Surg Oncol 2008, 97(7):609-614.
26. Gong X., Tang J., Geng X. Expression and significance of Annex in A7 in gastric cancer and lymphatic metastasis. Inter J Patho Clin Med 2009, 29(5):369-373.
27. Kataoka T.R., Ito A., Asada H., et al. Annexin VII as a novel marker for invasive phenotype of malignant melanoma. Jpn J Cancer Res 2000, 91(1):75-83.
28. Yang M., Liang Q. Study the relationship between the expression of Annexin A7 and CT of nasopharyngeal carcinoma. J Chin Clin Med Imaging 2011, 22(1):6-9.
29. Alfonso P., Canamero M., Fernandez-Carbonie F., et al. Proteome analysis of membrane fractions in colorectal carcinomas by using 2D-DIGE saturation labeling. J Proteome Res 2008, 7(10):4247-4255.
30. Jimenez C.R., Knol J.C., Meijer G.A., et al. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers. J Proteomics 2010, 73(10):1873-1895.
31. Xin W., Rhodes D.R., Ingold C., et al. Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol 2003, 162(1):255-261.
32. Srivastava M., Bubendorf L., Srikantan V., et al. ANX7, a candidate tumor suppressor gene for prostate cancer. Proc Natl Acad Sci USA 2001, 98(8):4575-4580.
33. Smitherman A.B., Mohler J.L., Maygarden S.J., et al. Expression of annexin I, II and VII proteins in androgen stimulated and recurrent prostate cancer. J Urol 2004, 171(2 Pt 1):916-920.
34. Torosyan Y., Simakova O., Naga S., et al. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells. Int J Cancer 2009, 125(11):2528-2539.
35. Srivastava M., Montagna C., Leighton X., et al. Haploinsufficiency of Anx7 tumor suppressor gene and consequent genomic instability promotes tumorigenesis in the Anx7(+/-) mouse. Proc Natl Acad Sci USA 2003, 100(24):14287-14292.
36. Lehnigk U., Zimmermann U., Woenckhaus C., et al. Localization of annexins I, II, IV and VII in whole prostate sections from radical prostatectomy patients. Histol Histopathol 2005, 20(3):673-680.
37. Leighton X., Srikantan V., Pollard H.B., et al. Significant allelic loss of ANX7 region (10q21) in hormone receptor negative breast carcinomas. Cancer Lett 2004, 210(2):239-244.
38. Torosyan Y., Dobi A., Glasman M., et al. Role of multi-hnRNP nuclear complex in regulation of tumor suppressor ANXA7 in prostate cancer cells. Oncogene 2010, 29(17):2457-2466.
39. Ji H., Moritz R.L., Kim Y.S., et al. Analysis of Ras-induced oncogenic transformation of NIH-3T3 cells using differential-display 2-DE proteomics. Electrophoresis 2007, 28(12):1997-2008.
40. Rozanov D.V., Savinov A.Y., Williams R., et al. Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer. Cancer Res 2008, 68(11):4086-4096.